Related Experiment Video
Updated: Jun 20, 2026
08:48
In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
Published on: November 5, 2021
Ergosterol biosynthesis and drug development for Chagas disease
1Instituto Venezolano de Investigaciones Científicas, Caracas, Venezuela. jurbina@mac.com
Memorias Do Instituto Oswaldo Cruz
|September 16, 2009
Summary
New ergosterol biosynthesis inhibitors show promise for treating Chagas disease, offering better efficacy and safety than current drugs like nifurtimox and benznidazole, especially against resistant strains.
Area of Science:
- Infectious Diseases
- Parasitology
- Drug Discovery
Background:
- Chagas disease is caused by Trypanosoma cruzi.
- Current treatments, nifurtimox (NFX) and benznidazole (BZN), have limitations.
- Drug resistance is a growing concern for Chagas disease treatment.
Purpose of the Study:
- To review current drugs for Chagas disease.
- To explore alternative treatments, focusing on ergosterol biosynthesis inhibitors (EBI).
- To assess the potential of EBIs as novel anti-Trypanosoma cruzi agents.
Main Methods:
- Review of existing literature on Chagas disease drugs.
- Focus on ergosterol biosynthesis inhibitors (EBIs) targeting T. cruzi.
- Analysis of in vitro and in vivo data for EBI candidates.
Main Results:
- Ergosterol biosynthesis inhibitors (EBIs) block essential parasite sterol production.
- Triazole derivatives targeting C14alpha sterol demethylase show promise, with posaconazole and ravuconazole advancing to clinical trials.
- EBIs demonstrate activity against NFX/BZN-resistant strains and improved safety profiles in preclinical models.
Conclusions:
- EBIs represent a promising new class of drugs for Chagas disease.
- Potential advantages include higher potency, selectivity, and better tolerability.
- Further clinical testing is required to confirm efficacy and safety in humans, particularly for chronic infections.
Related Concept Videos
01:22American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:29Biosynthesis of Lipids
Microbial membranes exhibit remarkable diversity in lipid composition, reflecting evolutionary adaptations to various environmental conditions. The three domains of life—Bacteria, Archaea, and Eukarya—synthesize membrane lipids through distinct biosynthetic pathways, leading to fundamental structural differences that impact membrane stability, function, and adaptability.Fatty Acid-Based Lipids in Bacteria and EukaryaBacteria and eukaryotes share a common fatty acid biosynthesis pathway, which...
01:18Production of Biopesticides
Biopesticides offer a sustainable alternative to chemical pesticides, utilizing microbial agents to control agricultural pests. Bacillus thuringiensis (Bt) is a widely employed bacterium known for its potent insecticidal activity. Bt biopesticides are favored for their specificity to insect pests, minimal environmental impact, and natural degradability.Mechanism of Bt Toxin Action Bt produces insecticidal crystal (Cry) proteins during its sporulation phase. These proteins form parasporal...